Diet Drug Acomplia Sales Disappoint; No Major Improvement Seen Until 2009
Sales of diet drug Acomplia (rimonabant) , available in Europe but not approved in the U.S., have turned into a major disappointment for Sanofi-Aventis, which says it does not expect the situation to significantly improve until new clinical trial results are ready for submission to regulators in [...]
Report in The Lancet Further Boosts Interest in Weight-Loss Drug Acomplia
A report published in this week’s issue of the prestigious medical journal, The Lancet, further stoked interest in the promising new weight-loss drug Acomplia (rimonabant) but in fact provided little new information.
The report was based on one-year results from the RIO–Europe clinical trial, which [...]
Diet Pill Acomplia Now Widely Available in Mexican Border Pharmacies
Diet drug Acomplia (rimonabant) , which seems at best months away from sale in the United States, is now widely available in pharmacies just across the Mexican border.
Readers increasingly are sending us reports on their experiences purchasing the highly anticipated diet pill in Mexican towns just across [...]
New Acomplia News Will Be Presented on March 8th
After a four-month dry spell during which there has been little news about development of the highly publicized obesity drug Acomplia (rimonabant) , researchers are scheduled to present new data from the RIO–Europe clinical trial at a scientific meeting in Orlando on Tuesday, March 8th.
The presentation of [...]
Encouraging Results Expected in Report June 12th on RIO-Diabetes Trial
Another round of good news about the diet–drug Acomplia (rimonabant) seems likely to be forthcoming on June 12th when researchers publicly report for the first time on results of the RIO-Diabetes trial at the American Diabetes Association’s annual scientific meeting in San Diego.
The year-long Rimonabant in [...]
2d Generic Version of Diet Pill Rimonabant (Acomplia / Zimulti) Launched in India
ond Acomplia (rimonabant) Indian pharmaceutical company, Torrent Pharmaceuticals Ltd., has announced that it also is selling a generic version of the new Sanofi-Aventis diet drug Acomplia (rimonabant) under the name Rimoslim.
The news, which attracted little attention in the West, occurred almost simultaneously with last week’s announcement by Zydus [...]
Most Significant ‘Wait Loss’ for Diet Drug Acomplia Is Loss of Sanofi’s Huge Lead
As month after month passes with no sign of imminent FDA action on diet drug rimonabant (Acomplia / Zimulti) , the most significant “wait loss” taking place is loss of the hugh lead Sanofi-Aventis once had in developing a novel approach to weight-loss based on [...]
Sanofi Allowed to Inform Patients Taking Acomplia That It Aids Blood Sugar Control
The European Commission has decided to let Sanofi-Aventis inform patients taking diet drug Acomplia (rimonabant) that the pill may also help in diabetic blood sugar control, but that does not mean it is approved to be prescribed as a diabetes drug.
The announcement, which ratified an [...]
